Chitosan glutamate nanoparticles for protein delivery: Development and effect on prolidase stability
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 24 (6) , 553-564
Abstract
Purpose: To evaluate the feasibility of exploiting ultrasonication coupled with ionotropic gelation in order to prepare tripolyphosphate (TPP)-chitosan glutamate nanoparticles suitable for the delivery of the enzyme prolidase. Methods: All the parameters for the preparation of TPP-chitosan nanoparticles in terms of components weight ratio, ultrasonication conditions and time-saving nanoparticles recovery conditions were optimized. The best formulation was loaded with the prolidase. All the nanoparticles were characterized in terms of morphology, size, polydispersity, zeta-potential, yield of the process and encapsulation efficiency. The in-vitro activity of the prolidase was assessed by capillary electrophoresis (CE). Results and conclusions: A TPP to chitosan weight ratio of 0.2:1 combined with one ultrasonication cycle (4 min using the probe-type sonifier at 75% power) obtained well-formed nanoparticles of spherical shape, mean size of ∼ 365 nm (polydispersity index 0.3) and a + 17.94 mV zeta potential. A satisfactory prolidase encapsulation efficiency (43%) was obtained with a yield of the preparation process of ∼55%. In vitro study of activity of prolidase, as free enzyme or released from chitosan nanoparticles, highlighted the ability of chitosan to stabilize the enzyme during all the steps of the preparation process and to modulate the enzyme activity up to 48 h.Keywords
This publication has 19 references indexed in Scilit:
- Natural polymers for gene delivery and tissue engineering☆Advanced Drug Delivery Reviews, 2006
- The role of emerging techniques in the investigation of prolidase deficiency: From diagnosis to the development of a possible therapeutical approachJournal of Chromatography B, 2006
- Modulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene deliveryColloids and Surfaces B: Biointerfaces, 2005
- Recent advances on chitosan-based micro- and nanoparticles in drug deliveryJournal of Controlled Release, 2004
- Nanoscale technology of mucoadhesive interactionsAdvanced Drug Delivery Reviews, 2004
- A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryVaccine, 2000
- Colorimetric Determination of ChitosanAnalytical Biochemistry, 1998
- Chitosan: A Unique Polysaccharide for Drug DeliveryDrug Development and Industrial Pharmacy, 1998
- Chitosan as a Nasal Delivery System: The Effect of Chitosan Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human Turbinates and VolunteersJournal of Pharmaceutical Sciences, 1997
- Determination of protein: A modification of the lowry method that gives a linear photometric responseAnalytical Biochemistry, 1972